Is America even ready for a coronavirus vaccine?
Even if the U.S. manages to develop an effective Covid-19 vaccine by Jan. 1, the country is fundamentally unprepared to manufacture and distribute the millions of doses required to halt the pandemic, according to two leading Democratic health policy figures.
As STAT’s Lev Facher reports, a new publication from the Center for American Progress calls on Congress to spend $40 billion to rapidly prepare the company for large-scale vaccine production. The current system is “haphazard,” according to co-authors Zeke Emanuel and Topher Spiro, risking major shortages of key materials that could create bottlenecks in the rollout of a vaccine.
“It’s very plausible that we could actually have an effective vaccine, and yet it might take a year and a half or two years for 300 million Americans to get to it because we haven’t planned properly and created the right kinds of infrastructure,” Emanuel said.
Read more.
As STAT’s Lev Facher reports, a new publication from the Center for American Progress calls on Congress to spend $40 billion to rapidly prepare the company for large-scale vaccine production. The current system is “haphazard,” according to co-authors Zeke Emanuel and Topher Spiro, risking major shortages of key materials that could create bottlenecks in the rollout of a vaccine.
“It’s very plausible that we could actually have an effective vaccine, and yet it might take a year and a half or two years for 300 million Americans to get to it because we haven’t planned properly and created the right kinds of infrastructure,” Emanuel said.
Read more.
.png)
No hay comentarios:
Publicar un comentario